TGA Approval

XARELTO rivaroxaban 1 mg/mL granules for oral suspension bottle (376019)

ARTG ID

376019

ARTG Name

XARELTO rivaroxaban 1 mg/mL granules for oral suspension bottle

Sponsor

Bayer Australia Ltd

ARTG Date

September 12, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BAYER AUSTRALIA LTD

Ingredient Name

rivaroxaban

Empowering clinical research with data-driven insights and AI-powered tools.

XARELTO rivaroxaban 1 mg/mL granules for oral suspension bottle (376019) - TGA 批准文号 | MedPath